Clinical trial Recruiting at 1 site Observational Ages 2 Weeks to 25

Triple Electrical Impedance Tomography (EIT) lung imaging in neonates, children, and young adults

Official title: Characterizing the Evolution of Neonatal Lung Disease Throughout Infancy and Childhood Using Electrical Impedance Tomography: A Pilot Study

Run by University of Colorado, Denver · NCT07247474 · Data updated 2026-11-12

This study will try using electrical impedance tomography (EIT) to compare lung images of infants, children, and young adults with cardiopulmonary disease to those without lung disease.

Quick facts

Study typeObservational
Ages2 Weeks to 25 Years
SexAll
Enrollment140 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Drugs / interventionsradiation
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedJanuary 30, 2026
Main results expectedNovember 2028
Study endsDecember 2028
Registry record updatedFebruary 23, 2026
Trial IDNCT07247474 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 2 weeks to 25 years who either have cardiopulmonary disease as listed in the eligibility criteria or are healthy term-born controls with no cardiopulmonary disease.

Probably not a fit

Patients younger than 2 weeks, those who cannot have electrodes placed on the chest (for example due to skin problems, large dressings, or multiple chest tubes), people with intrathoracic metal implants like pacemakers, pregnant or lactating patients, and those who do not provide informed consent would not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses non‑ionizing electrical impedance tomography (EIT) to image lung structure and ventilation via chest electrodes, similar to how an EKG reads the heart. Participants aged 2 weeks to 25 years will include those with a range of cardiopulmonary conditions (for example post-prematurity respiratory disease, congenital diaphragmatic hernia, pulmonary hypertension, congenital heart disease, respiratory failure, neuromuscular disease, or developmental lung disorders) and matched healthy term-born controls. Investigators will compare EIT measurements between the disease and control groups to characterize lung composition and ventilation patterns without using CT or X‑ray. Participants with contraindications to electrode placement, pacemakers or other intrathoracic metal implants, pregnancy, or inability to give informed consent will be excluded.

Why it matters

Potential benefit: If successful, this approach could provide a safer, bedside way to better understand and monitor lung structure and function in infants and children without exposure to radiation.

How similar studies have gone: EIT has been used successfully in other neonatal and adult respiratory studies to monitor ventilation distribution, but methods are still being refined and it is not yet standard clinical practice everywhere.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 2 weeks to 25 years of age
* evidence of cardiopulmonary disease including, but not limited to:

  1. Post-prematurity respiratory disease
  2. Congenital diaphragmatic hernia
  3. Pulmonary Hypertension
  4. Congenital heart disease
  5. Respiratory failure
  6. Neuromuscular Disease
  7. Developmental or congenital lung disease

OR matched healthy controls (born at term gestation (\>36 weeks gestational age) with no cardiopulmonary disease)

Exclusion Criteria:

* \<2 weeks of age
* Anything that interferes with lead placement on the chest wall (such as, dermatologic conditions, multiple chest tubes, anatomic abnormality, or large dressings that cannot be moved)
* No informed consent
* Pregnant or lactating
* Pacemaker or other metal intrathoracic surgical implant (causes noise in the data)

Where it's running

  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.